サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/18 | 851 | 919 | 850 | 893 | -127 | -12.5% | 3,348,900 |
| 2024/11/15 | 1,035 | 1,035 | 1,009 | 1,020 | -19 | -1.8% | 596,300 |
| 2024/11/14 | 1,035 | 1,058 | 1,023 | 1,039 | -19 | -1.8% | 495,900 |
| 2024/11/13 | 1,091 | 1,109 | 1,050 | 1,058 | -37 | -3.4% | 526,300 |
| 2024/11/12 | 1,088 | 1,130 | 1,088 | 1,095 | +10 | +0.9% | 909,000 |
| 2024/11/11 | 1,070 | 1,088 | 1,055 | 1,085 | +5 | +0.5% | 425,200 |
| 2024/11/08 | 1,031 | 1,098 | 1,031 | 1,080 | +47 | +4.5% | 841,200 |
| 2024/11/07 | 1,042 | 1,067 | 1,026 | 1,033 | -8 | -0.8% | 611,900 |
| 2024/11/06 | 1,025 | 1,055 | 1,022 | 1,041 | +7 | +0.7% | 444,900 |
| 2024/11/05 | 1,006 | 1,049 | 991 | 1,034 | +21 | +2.1% | 681,100 |
| 2024/11/01 | 1,001 | 1,025 | 995 | 1,013 | +3 | +0.3% | 699,000 |
| 2024/10/31 | 1,089 | 1,094 | 1,001 | 1,010 | +5 | +0.5% | 1,766,500 |
| 2024/10/30 | 1,015 | 1,019 | 1,001 | 1,005 | -1 | -0.1% | 355,500 |
| 2024/10/29 | 1,024 | 1,035 | 1,006 | 1,006 | -10 | -1% | 338,800 |
| 2024/10/28 | 996 | 1,020 | 991 | 1,016 | +19 | +1.9% | 604,200 |
| 2024/10/25 | 982 | 1,012 | 982 | 997 | +3 | +0.3% | 569,800 |
| 2024/10/24 | 1,009 | 1,018 | 986 | 994 | -31 | -3% | 787,100 |
| 2024/10/23 | 1,042 | 1,056 | 1,013 | 1,025 | +3 | +0.3% | 535,600 |
| 2024/10/22 | 1,041 | 1,049 | 1,013 | 1,022 | -18 | -1.7% | 446,900 |
| 2024/10/21 | 1,044 | 1,075 | 1,037 | 1,040 | +5 | +0.5% | 643,600 |
| 2024/10/18 | 1,031 | 1,036 | 1,020 | 1,035 | +6 | +0.6% | 424,300 |
| 2024/10/17 | 1,040 | 1,058 | 1,029 | 1,029 | -17 | -1.6% | 556,500 |
| 2024/10/16 | 1,040 | 1,058 | 1,024 | 1,046 | -11 | -1% | 556,200 |
| 2024/10/15 | 1,055 | 1,083 | 1,051 | 1,057 | -12 | -1.1% | 642,700 |
| 2024/10/11 | 1,114 | 1,120 | 1,066 | 1,069 | -62 | -5.5% | 1,079,100 |
| 2024/10/10 | 1,112 | 1,150 | 1,095 | 1,131 | +21 | +1.9% | 1,167,800 |
| 2024/10/09 | 1,159 | 1,186 | 1,097 | 1,110 | -48 | -4.1% | 1,585,100 |
| 2024/10/08 | 1,193 | 1,194 | 1,145 | 1,158 | -35 | -2.9% | 946,100 |
| 2024/10/07 | 1,204 | 1,210 | 1,169 | 1,193 | +7 | +0.6% | 1,019,800 |
| 2024/10/04 | 1,220 | 1,228 | 1,178 | 1,186 | -34 | -2.8% | 1,310,500 |
| 2024/10/03 | 1,316 | 1,320 | 1,220 | 1,220 | -59 | -4.6% | 2,727,400 |
| 2024/10/02 | 1,279 | 1,351 | 1,270 | 1,279 | -36 | -2.7% | 4,797,700 |
| 2024/10/01 | 1,155 | 1,363 | 1,153 | 1,315 | +162 | +14.1% | 5,800,600 |
| 2024/09/30 | 1,180 | 1,218 | 1,150 | 1,153 | -29 | -2.5% | 1,746,700 |
| 2024/09/27 | 1,206 | 1,247 | 1,175 | 1,182 | ±0 | ±0% | 2,026,800 |
| 2024/09/26 | 1,243 | 1,290 | 1,175 | 1,182 | -180 | -13.2% | 5,177,300 |
| 2024/09/25 | 1,245 | 1,385 | 1,212 | 1,362 | +124 | +10% | 11,443,500 |
| 2024/09/24 | 1,340 | 1,341 | 1,183 | 1,238 | -57 | -4.4% | 6,909,500 |
| 2024/09/20 | 1,133 | 1,319 | 1,099 | 1,295 | +213 | +19.7% | 11,772,900 |
| 2024/09/19 | 992 | 1,096 | 988 | 1,082 | +120 | +12.5% | 4,549,300 |
| 2024/09/18 | 922 | 980 | 915 | 962 | +22 | +2.3% | 1,211,000 |
| 2024/09/17 | 980 | 980 | 921 | 940 | -22 | -2.3% | 828,800 |
| 2024/09/13 | 978 | 981 | 944 | 962 | -7 | -0.7% | 582,000 |
| 2024/09/12 | 949 | 977 | 923 | 969 | +49 | +5.3% | 925,100 |
| 2024/09/11 | 950 | 952 | 905 | 920 | -37 | -3.9% | 1,198,000 |
| 2024/09/10 | 957 | 965 | 940 | 957 | +5 | +0.5% | 568,700 |
| 2024/09/09 | 893 | 963 | 882 | 952 | +14 | +1.5% | 1,019,600 |
| 2024/09/06 | 1,018 | 1,036 | 932 | 938 | -33 | -3.4% | 3,784,500 |
| 2024/09/05 | 981 | 993 | 967 | 971 | -9 | -0.9% | 660,500 |
| 2024/09/04 | 973 | 1,003 | 971 | 980 | -16 | -1.6% | 1,279,700 |
151～
200
件表示中 / 2500件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 233,200円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| キッセイ薬 | 401,000円 | +3.6% | +6.1% | 2.99% | 13.51倍 | 0.80倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 科研薬 | 379,100円 | -6.4% | -71.8% | 5.01% | 42.34倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 330,000円 | +21.7% | +999.9% | 0.00% | 13.83倍 | 4.76倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
